Michael P. Thirlwell, MD
Axe de recherche primaire:
Cancer
Courriel:
Courriel Le but de la recherche:
Recherche clinique sur le traitement de tumeurs solides et le soulagement de symptômes dus au cancer et aux agents anticancéreux. Les sites tumoraux d’intérêt particulier sont le cancer du sein et le cancer colorectal.Essais cliniques sur le cancer, cancer du sein, cancer colorectal, soins de soutien
Mots-clés:
Essais cliniques sur le cancer, cancer du sein, cancer colorectal, soins de soutien
Emplacement:
Montreal General Hospital Publications:
Thirlwell M, Nercessian A, Legler C, Duero D, Ayoub J, Cragg L, Hings I. A pilot study of a new scalp cooling system to reduce alopecia in cancer patients receiving chemotherapy. Proceedings of the 17th International Congress of UICC 1998; 2: 1457-1459.
Frenette PS, Thirlwell MP, Trudeau M, Thomson DMP, Joseph L, Shuster JS. The Diagnostic Value of A 27-29, CA 15-3, Mucin-Like Carcinoma Antigen (MCA), Carcinembrionic Antigen (CEA) and CA 19-9 in Breast and Gastrointestinal Malignancies. Tumor Biology 1994; 15: 247-254.
Wolmark N, Rockette H, Wickerman D, Fisher B, Redmond C, Fisher ER, Potvin M, Davies RJ, Jones J, Robidoux A, Wexler M, Gordon P, Cruz AB, Horsley S Jr, Nims TA, Thirlwell M, Phillips WA, Prager D, Stern H, Lerner HJ, Frazier TG. Adjuvant Therapy of Duke’s A, B and C Adenocarcinoma of the Colon with Portal-Vein Fluorouracil Hepatic Infusion: Preliminary Results of National Surgical Adjuvant Breast and Bowel Project. Journal of Clinical Oncology 1990; 8:1466-1475.
